Terms: = Lung cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Prognosis
18 results:
1. Comprehensive characterization of B7 family members in NSCLC and identification of its regulatory network.
Xiao M; Pang C; Xiang S; Zhao Y; Wu X; Li M; Du F; Chen Y; Wang F; Wen Q; Xiao Z; Yang Z; Shen J
Sci Rep; 2023 Mar; 13(1):4311. PubMed ID: 36922519
[TBL] [Abstract] [Full Text] [Related]
2. Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge
Iksen I; Sinsook S; Wattanathamsan O; Buaban K; Chamni S; Pongrakhananon V
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558080
[TBL] [Abstract] [Full Text] [Related]
3. Multi-Omics Immune Interaction Networks in lung cancer Tumorigenesis, Proliferation, and Survival.
Ye Q; Hickey J; Summers K; Falatovich B; Gencheva M; Eubank TD; Ivanov AV; Guo NL
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499305
[TBL] [Abstract] [Full Text] [Related]
4. Heat shock protein 90 inhibitor 17-AAG down-regulates thymidine phosphorylase expression and potentiates the cytotoxic effect of tamoxifen and erlotinib in human lung squamous carcinoma cells.
Ko JC; Chen JC; Hsieh JM; Tseng PY; Chiang CS; Liu LL; Chien CC; Huang IH; Chang QZ; Mu BC; Lin YW
Biochem Pharmacol; 2022 Oct; 204():115207. PubMed ID: 35961402
[TBL] [Abstract] [Full Text] [Related]
5. Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule.
Lawal B; Wu ATH; Huang HS
Front Immunol; 2022; 13():872470. PubMed ID: 35655775
[TBL] [Abstract] [Full Text] [Related]
6. Clinical study of map2k1-mutated Langerhans cell histiocytosis in children.
Yang Y; Wang C; Wang D; Cui L; Li N; Lian H; Ma H; Zhao Y; Zhang L; Liu W; Wang Y; Wu W; Zhang R; Li Z; Wang T
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2517-2527. PubMed ID: 34595543
[TBL] [Abstract] [Full Text] [Related]
7. Integrative pan-cancer analysis of mek1 aberrations and the potential clinical implications.
Zhou Z; Peng B; Li J; Gao K; Cai Y; Xu Z; Yan Y
Sci Rep; 2021 Sep; 11(1):18366. PubMed ID: 34526571
[TBL] [Abstract] [Full Text] [Related]
8. GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78.
Song J; Liu W; Wang J; Hao J; Wang Y; You X; Du X; Zhou Y; Ben J; Zhang X; Ye M; Wang Q
Cell Death Dis; 2020 May; 11(5):352. PubMed ID: 32393740
[TBL] [Abstract] [Full Text] [Related]
9. CIAPIN1 Targeted NHE1 and ERK1/2 to Suppress NSCLC Cells' Metastasis and Predicted Good prognosis in NSCLC Patients Receiving Pulmonectomy.
Wang J; Zhou Y; Ma L; Cao S; Gao W; Xiong Q; Wang K; Yang L
Oxid Med Cell Longev; 2019; 2019():1970818. PubMed ID: 31093311
[TBL] [Abstract] [Full Text] [Related]
10. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract] [Full Text] [Related]
11. EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP).
Cardona AF; Rojas L; Zatarain-Barrón ZL; Freitas HC; Granados ST; Castillo O; Oblitas G; Corrales L; Castro CD; Ruiz-Patiño A; Martín C; Pérez MA; González L; Chirinos L; Vargas C; Carranza H; Otero J; Rodriguez J; Rodriguez J; Archila P; Lema M; Acosta Madiedo J; Karachaliu N; Wills B; Pino LE; de Lima V; Rosell R; Arrieta O;
Lung Cancer; 2018 Nov; 125():265-272. PubMed ID: 30429031
[TBL] [Abstract] [Full Text] [Related]
12. Identification of inhibitors synergizing gemcitabine sensitivity in the squamous subtype of pancreatic ductal adenocarcinoma (PDAC).
Er JL; Goh PN; Lee CY; Tan YJ; Hii LW; Mai CW; Chung FF; Leong CO
Apoptosis; 2018 Jun; 23(5-6):343-355. PubMed ID: 29740790
[TBL] [Abstract] [Full Text] [Related]
13. BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.
Kwon OS; Hong SK; Kwon SJ; Go YH; Oh E; Cha HJ
Cancer Lett; 2017 Sep; 403():48-58. PubMed ID: 28606806
[TBL] [Abstract] [Full Text] [Related]
14. FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells.
Yuan H; Li ZM; Shao J; Ji WX; Xia W; Lu S
J Exp Clin Cancer Res; 2017 May; 36(1):72. PubMed ID: 28558758
[TBL] [Abstract] [Full Text] [Related]
15. Profiling of Oncogenic Driver Events in lung Adenocarcinoma Revealed MET Mutation as Independent Prognostic Factor.
Yeung SF; Tong JHM; Law PPW; Chung LY; Lung RWM; Tong CYK; Chow C; Chan AWH; Wan IYP; Mok TSK; To KF
J Thorac Oncol; 2015 Sep; 10(9):1292-1300. PubMed ID: 26098749
[TBL] [Abstract] [Full Text] [Related]
16. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
Khan S; Shukla S; Sinha S; Lakra AD; Bora HK; Meeran SM
Int J Biochem Cell Biol; 2015 Jan; 58():1-16. PubMed ID: 25448414
[TBL] [Abstract] [Full Text] [Related]
17. Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells.
Ko JC; Huang YC; Chen HJ; Tseng SC; Chiu HC; Wo TY; Huang YJ; Weng SH; Chiou RY; Lin YW
Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):56-65. PubMed ID: 23362830
[TBL] [Abstract] [Full Text] [Related]
18. Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth.
Fournier G; Cabaud O; Josselin E; Chaix A; Adélaïde J; Isnardon D; Restouin A; Castellano R; Dubreuil P; Chaffanet M; Birnbaum D; Lopez M
Oncogene; 2011 Sep; 30(36):3862-74. PubMed ID: 21478912
[TBL] [Abstract] [Full Text] [Related]
